| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 623879 | Null | 0.00349006332443474 | -0.090456458 |
| NSC 132791 | Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo | 0.00485717408280859 | -0.10107732 |
| NSC 133118 | 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) | 0.00485717408280859 | 0.2447987 |
| NSC 709437 | Null | 0.00485717408280859 | -0.018435921 |
| NSC 715399 | Null | 0.00485717408280859 | -0.012396958 |
| NSC 727667 | 4,4'-[1,3-phenylenebis(methyleneoxy)] bisbenzenecarboximidamide, dihydrochloride salt | 0.00485717408280859 | -0.024781958 |
| NSC 106486 | Formycin B | 0.00503396694999381 | 0.26555581 |
| NSC 139948 | Null | 0.00617256681787881 | 0.1553668 |
| NSC 140380 | Ethanesulfonic acid, compd. with 4-[[2-chloro-4-(4,6-diamino-2,2-dimethyl-1,3,5-triazin-1(2H)-yl)phenoxy]acetyl]morpholine (1:1) (9CI) (MF2) | 0.00617256681787881 | -0.09119095 |
| NSC 57048 | 2-Azaadenine | 0.00617256681787881 | 0.36789346 |